Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Brain Glioblastoma
  • Estrogen Receptor Negative
  • Extensive Stage Small Cell Lung Carcinoma
  • Stage IIA Pancreatic Cancer
  • Stage IV Non-small Cell Lung Cancer
  • Stage IIIA Skin Melanoma
  • Stage IIIC Gastric Cancer
  • Stage IIB Pancreatic Cancer
  • Stage IIC Rectal Cancer
  • Stage II Pancreatic Cancer
  • Stage III Gastric Cancer
  • Stage IIIB Colon Cancer
  • Stage IIIC Rectal Cancer
  • Stage IIB Rectal Cancer
  • Stage IV Rectal Cancer
  • Stage IVA Rectal Cancer
  • Stage IIIB Ovarian Cancer
  • Stage IV Gastric Cancer
  • Stage IVA Bone Sarcoma
  • Head and Neck Carcinoma
  • Stage III Skin Melanoma
  • Stage IIIA Rectal Cancer
  • Stage IVB Rectal Cancer
  • Stage IVA Colon Cancer
  • Stage IIIB Esophageal Cancer
  • Stage IV Bone Sarcoma
  • Stage IV Bladder Cancer
  • Stage IV Esophageal Cancer
  • Stage IVB Colon Cancer
  • Stage IIIC Skin Melanoma
  • HER2/Neu Negative
  • Stage III Rectal Cancer
  • Stage IIIA Colon Cancer
  • Stage IIIA Esophageal Cancer
  • Stage IIIC Colon Cancer
  • Stage IV Skin Melanoma
  • Stage III Colon Cancer
  • Stage IV Ovarian Cancer
  • Hormone-Resistant Prostate Cancer
  • Stage III Ovarian Cancer
  • Stage III Esophageal Cancer
  • Stage IIIB Skin Melanoma
  • Recurrent Carcinoma
  • Limited Stage Small Cell Lung Carcinoma
  • Stage IIIB Non Small Cell Lung Cancer
  • Triple-Negative Breast Carcinoma
  • Stage III Pancreatic Cancer
  • Stage IIIC Ovarian Cancer
  • Stage IIIB Rectal Cancer
  • Stage IIA Rectal Cancer
  • Stage IIIA Ovarian Cancer
  • Stage IV Renal Cell Cancer
  • Stage IIIC Esophageal Cancer
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage III Non-Small Cell Lung Cancer
  • Progesterone Receptor Negative
  • Stage II Rectal Cancer
  • Stage IV Colon Cancer
  • Stage IIIA Gastric Cancer
  • Stage IIIB Gastric Cancer
  • Stage IV Soft Tissue Sarcoma
  • Stage IV Breast Cancer
  • Stage IV Pancreatic Cancer
  • Stage IVB Bone Sarcoma
  • Progressive Disease
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Health Services Research

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJ...

PRIMARY OBJECTIVES: I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities. SECONDARY OBJECTIVES: I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive usual care. ARM B: Patients undergo health care coach support with a baseline introduction (either telephonic or in-person) of the program followed by a visit (telephonic or in-person) with the health care coach after the first oncology appointment to discuss goals of care. The health care coach will contact patient based on patients' ongoing needs (weekly to monthly) and will conduct symptom assessments based on patients' treatment plans and symptoms. After completion of study, patients are followed up for 6 months.

Tracking Information

NCT #
NCT03154190
Collaborators
Not Provided
Investigators
Principal Investigator: Manali Patel Stanford University